Featured
Status
Health Topics
- Analytical, Diagnostic and Therapeutic Techniques and Equipment40 See more
- Anthropology, Education, Sociology and Social Phenomena4 See more
-
Chemicals and Drugs400
See more
- Amino Acids, Peptides, and Proteins 103
- Biological Factors 25
- Biomedical and Dental Materials 1
- Carbohydrates 16
- Chemical Actions and Uses 63
- Complex Mixtures 32
- Enzymes and Coenzymes 11
- Heterocyclic Compounds 130
- Hormones, Hormone Substitutes, and Hormone Antagonists 31
- Inorganic Chemicals 47
- Lipids 12
- Macromolecular Substances 2
- Nucleic Acids, Nucleotides, and Nucleosides 24
- Organic Chemicals 202
- Pharmaceutical Preparations 10
- Polycyclic Compounds 62
-
Diseases887
See more
- Animal Diseases 1
- Bacterial Infections and Mycoses 65
- Cardiovascular Diseases 92
- Chemically-Induced Disorders 38
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities 125
- Digestive System Diseases 89
- Endocrine System Diseases 73
- Eye Diseases 16
- Female Urogenital Diseases and Pregnancy Complications 95
- Hemic and Lymphatic Diseases 117
- Immune System Diseases 126
- Male Urogenital Diseases 78
- Musculoskeletal Diseases 43
- Neoplasms 215
- Nervous System Diseases 147
- Nutritional and Metabolic Diseases 121
- Occupational Diseases 4
- Otorhinolaryngologic Diseases 20
- Parasitic Diseases 13
- Pathological Conditions, Signs and Symptoms 294
- Respiratory Tract Diseases 45
- Skin and Connective Tissue Diseases 40
- Stomatognathic Diseases 17
- Virus Diseases 68
- Wounds and Injuries 30
- Health Care7 See more
-
Phenomena and Processes58
See more
- Psychiatry and Psychology133 See more
- Technology, Industry, Agriculture7 See more
Search Clinical Trials
Available
SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury (External Link)
Therapy with SMOFlipid will be provided at a targeted dose of 3 gm/kg/day (by continuous infusion). SMOFlipid will be initiated and advanced according to the following guidelines: Day 1 - …
Baylor Role:
Lead Sponsor
No Longer Available
Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia (External Link)
Hyperinsulinemic hypoglycemia is caused by low glucose due to excessive insulin secretion and remains difficult to treat because of the requirement for extensive amounts of glucose and the lack of …
Baylor Role:
Lead Sponsor